Tafamidis Impurities and its Related Products




Displaying 8 results of Tafamidis Impurities

Tafamidis Impurities are the unwanted substances present in Tafamidis, a medication used to treat a rare genetic disease called transthyretin amyloidosis. These impurities can affect the efficacy and safety of the drug and may cause adverse effects. Therefore, it is important to identify, monitor and control these impurities to ensure the quality, safety, and potency of the medication.

TAFAMIDIS IMPURITIES, IMPURITIES
2-(2-chlorophenyl)-1,3-benzoxazole-5-carboxylic acid


CAT No. : CS-ED-00868
Mol F. : C₁₄H₈ClNO₃
Mol W. : 273.67 g/mol
Cas No. : 1018498-30-0
Stock : In Stock

TAFAMIDIS IMPURITIES, IMPURITIES
2-(3,4-Dichlorophenyl)-6-benzoxazolecarboxylic acid methyl ester


CAT No. : CS-O-40355
Mol F. : C₁₅H₉Cl₂NO₃
Mol W. : 322.14 g/mol
Cas No. : 2306320-67-0
Stock : In Stock

TAFAMIDIS IMPURITIES, IMPURITIES
Di-deschloro Tafamidis


CAT No. : CS-O-56413
Mol F. : C₁₄H₉NO₃
Mol W. : 239.23 g/mol
Cas No. : 594839-90-4
Stock : In Stock

TAFAMIDIS IMPURITIES, IMPURITIES
Tafamidis Impurity 3


CAT No. : CS-O-40351
Mol F. : C₁₄H₉Cl₂NO₄
Mol W. : 326.13 g/mol
Cas No. : 1184581-58-5
Stock : In Stock

TAFAMIDIS IMPURITIES, IMPURITIES
Tafamidis Impurity 4


CAT No. : CS-O-40353
Mol F. : C₁₄H₇Cl₂NO₃
Mol W. : 308.12 g/mol
Cas No. : 1507158-86-2
Stock : Enquire

TAFAMIDIS IMPURITIES, IMPURITIES
Tafamidis Impurity 5


CAT No. : CS-O-40354
Mol F. : C₁₄H₈ClNO₃
Mol W. : 273.67 g/mol
Cas No. : 1521571-08-3
Stock : In Stock

TAFAMIDIS IMPURITIES, IMPURITIES
Tafamidis Impurity 6


CAT No. : CS-O-40400
Mol F. : C₁₅H₉Cl₂NO₃
Mol W. : 322.14 g/mol
Cas No. : 1395964-06-3
Stock : In Stock

TAFAMIDIS IMPURITIES, IMPURITIES
Tafamidis meglumine


CAT No. : CS-N-05179
Mol F. : C21H24Cl2N2O8
Mol W. : 503.33 g/mol
Cas No. : 951395-08-7
Stock : Enquire